Havana (Reuters) – Cuba and China signed Saturday a

agreement to promote biotechnology among both cooperation

Nations and promote research for the development of

vaccines.

China has injected billions of dollars in

loans to Cuba in recent years, has become in his

main creditor and its second largest trading partner after

Venezuela, which is its economic ally number one in the world.

“Cuba and China today drew its lines of work in the

biotechnology in the next five years research

2012-2016, aimed at strengthening the Exchange in this

discipline”, said Prensa Latina News Agency, quoting

a meeting of two days between both scientific authorities

countries.

Beijing and Havana signed an agreement between the company

china Hualan Biological Bacterial and the Finlay Institute of

Cuba, aimed at the development research of

vaccines, said the Agency.

The Minister of science, technology and environment of

Cuba, Jose Miyar Barruecos, said that “cooperation in the

biotechnology between Cuba and China field is of a nature

strategy”.

A Chinese diplomatic source in Havana said that more than

200 companies in his country have relations with Cuba.

And more than 20 companies and Cuban entities have been established in

Beijing, Hangzhou, Shenzhsen and other cities in the nation

Asian.

Beijing reported that during the last decade the Exchange

commercial bilateral increased from $ 440 million

in 2001 to 1.830 million dollars by 2010,

according to figures official.

Cuba currently produces approximately 38 medicines which are

they traded in some 40 countries.

Laboratories of the island produce vaccines against the

meningitis B and C, leptospirosis, typhoid fever and a

synthetic vaccine against haemophilus influenzae type B, the

main causes of meningitis and other infections

children’s.